Gene and Protein Expression Profiles After Treatment of Actinic Keratoses

Clinical trial NCT05740969 · UNKNOWN

Trial details

NCT number: NCT05740969
Sponsor: Ismail Gögenur
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Actinic Keratoses

Start date: 2023-02-01
Primary completion: 2024-02-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.